Evidence map›Paper›PMID 36003908›Full record

ArticleFrontiers in cardiovascular medicine2022

Case report: Unusual coexistence between familial hypercholesterolemia and familial hypobetalipoproteinemia.

Kei Sasaki, Hayato Tada, Masa-Aki Kawashiri, Toshimitsu Ito

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kei SasakiDepartment of Internal Medicine, Self-Defense Forces Central Hospital, Tokyo, Japan.
Hayato TadaDivision of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Masa-Aki KawashiriDivision of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Toshimitsu ItoDepartment of Internal Medicine, Self-Defense Forces Central Hospital, Tokyo, Japan.
Kanazawa University · JPSelf-Defense Forces Central Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 1 familial hypobetalipoproteinemia (FHBL1), characterized by low levels of apolipoprotein B (ApoB)-containing lipoproteins, elevation of transaminases, and hepatic steatosis, is a rare disease the prevalence of which is 1 in 3,000 among general population. Here we report an extremely rare family where phenotypes of familial hypercholesterolemia (FH) are canceled by coexistence of FHBL1 caused by an truncating mutation in apolipoprotein B (

Indexed as

apolipoprotein Bfamilial hypercholesterolemiafamilial hypobetalipoproteinemiaLDL cholesterolPCSK9

Identifiers

PMID36003908
PMCPMC9393375
OpenAlexW4290546759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.